1. Home
  2. VABK vs EDIT Comparison

VABK vs EDIT Comparison

Compare VABK & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.50

Market Cap

215.8M

Sector

Finance

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.06

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
EDIT
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
206.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
VABK
EDIT
Price
$40.50
$2.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.50
AVG Volume (30 Days)
5.8K
1.9M
Earning Date
01-23-2026
03-04-2026
Dividend Yield
3.63%
N/A
EPS Growth
14.22
N/A
EPS
3.30
N/A
Revenue
$56,512,000.00
$46,383,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.01
N/A
Revenue Growth
10.39
N/A
52 Week Low
$34.12
$0.91
52 Week High
$44.57
$4.54

Technical Indicators

Market Signals
Indicator
VABK
EDIT
Relative Strength Index (RSI) 51.19 44.40
Support Level $39.10 $2.05
Resistance Level $40.43 $2.17
Average True Range (ATR) 0.63 0.15
MACD 0.04 0.01
Stochastic Oscillator 65.12 27.27

Price Performance

Historical Comparison
VABK
EDIT

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Share on Social Networks: